182 related articles for article (PubMed ID: 23158209)
1. Protein gene product 9.5 is diagnostically helpful in delineating high-grade renal cell cancer involving the renal medullary/sinus region from invasive urothelial cell carcinoma of the renal pelvis.
Gunia S; Erbersdobler A; Koch S; Otto W; Staibano S; D'Alterio C; Brookman-May S
Hum Pathol; 2013 May; 44(5):712-7. PubMed ID: 23158209
[TBL] [Abstract][Full Text] [Related]
2. p63, CK7, PAX8 and INI-1: an optimal immunohistochemical panel to distinguish poorly differentiated urothelial cell carcinoma from high-grade tumours of the renal collecting system.
Carvalho JC; Thomas DG; McHugh JB; Shah RB; Kunju LP
Histopathology; 2012 Mar; 60(4):597-608. PubMed ID: 22260386
[TBL] [Abstract][Full Text] [Related]
3. The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomas.
Gonzalez-Roibon N; Albadine R; Sharma R; Faraj SF; Illei PB; Argani P; Ertoy D; Allaf ME; Netto GJ
Hum Pathol; 2013 Dec; 44(12):2651-7. PubMed ID: 24071011
[TBL] [Abstract][Full Text] [Related]
4. Collecting duct carcinoma of the kidney: an immunohistochemical evaluation of the use of antibodies for differential diagnosis.
Kobayashi N; Matsuzaki O; Shirai S; Aoki I; Yao M; Nagashima Y
Hum Pathol; 2008 Sep; 39(9):1350-9. PubMed ID: 18602672
[TBL] [Abstract][Full Text] [Related]
5. Primary carcinoma of renal calyx.
Williams PA; Mai KT
Pathol Res Pract; 2013 Oct; 209(10):654-61. PubMed ID: 23999038
[TBL] [Abstract][Full Text] [Related]
6. [Comparative morphological characteristics and immunophenotype of urothelial carcinomas of the renal pelvis and bladder].
Osmanov YI; Gaibov ZA; Kogan EA; Radenska-Lopovok SG; Tursunov KZ
Arkh Patol; 2018; 80(5):23-32. PubMed ID: 30335057
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical diagnosis of renal neoplasms.
Truong LD; Shen SS
Arch Pathol Lab Med; 2011 Jan; 135(1):92-109. PubMed ID: 21204715
[TBL] [Abstract][Full Text] [Related]
8. Multiple cytokeratin-negative malignant tumors composed only of rhabdoid cells in the renal pelvis: a sarcomatoid urothelial carcinoma?
Terada T
Int J Clin Exp Pathol; 2013; 6(4):724-8. PubMed ID: 23573320
[TBL] [Abstract][Full Text] [Related]
9. PAX8 (+)/p63 (-) immunostaining pattern in renal collecting duct carcinoma (CDC): a useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tract.
Albadine R; Schultz L; Illei P; Ertoy D; Hicks J; Sharma R; Epstein JI; Netto GJ
Am J Surg Pathol; 2010 Jul; 34(7):965-9. PubMed ID: 20463571
[TBL] [Abstract][Full Text] [Related]
10. MET expression in sporadic renal cell carcinomas.
Choi JS; Kim MK; Seo JW; Choi YL; Kim DH; Chun YK; Ko YH
J Korean Med Sci; 2006 Aug; 21(4):672-7. PubMed ID: 16891811
[TBL] [Abstract][Full Text] [Related]
11. Immunohistochemical profile of common epithelial neoplasms arising in the kidney.
Kim MK; Kim S
Appl Immunohistochem Mol Morphol; 2002 Dec; 10(4):332-8. PubMed ID: 12613443
[TBL] [Abstract][Full Text] [Related]
12. Renal collecting (Bellini) duct carcinoma displays similar characteristics to upper tract urothelial cell carcinoma.
Orsola A; Trias I; Raventós CX; Español I; Cecchini L; Orsola I
Urology; 2005 Jan; 65(1):49-54. PubMed ID: 15667862
[TBL] [Abstract][Full Text] [Related]
13. Papillary renal cell carcinoma with cytologic and molecular genetic features overlapping with renal oncocytoma: Analysis of 10 cases.
Michalova K; Steiner P; Alaghehbandan R; Trpkov K; Martinek P; Grossmann P; Montiel DP; Sperga M; Straka L; Prochazkova K; Cempirkova D; Horava V; Bulimbasic S; Pivovarcikova K; Daum O; Ondic O; Rotterova P; Michal M; Hora M; Hes O
Ann Diagn Pathol; 2018 Aug; 35():1-6. PubMed ID: 30072012
[TBL] [Abstract][Full Text] [Related]
14. Renal cell carcinoma invading the urinary collecting system: implications for staging.
Uzzo RG; Cherullo E; Myles J; Novick AC
J Urol; 2002 Jun; 167(6):2392-6. PubMed ID: 11992044
[TBL] [Abstract][Full Text] [Related]
15. Cytopathology of retrograde renal pelvis brush specimens: an analysis of 40 cases with emphasis on collecting duct carcinoma and low-intermediate grade transitional cell carcinoma.
Zaman SS; Sack MJ; Ramchandani P; Tomaszewski JE; Gupta PK
Diagn Cytopathol; 1996 Nov; 15(4):312-21. PubMed ID: 8982587
[TBL] [Abstract][Full Text] [Related]
16. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
[TBL] [Abstract][Full Text] [Related]
17. PAX2 and PAX8 expression in primary and metastatic renal tumors: a comprehensive comparison.
Ozcan A; de la Roza G; Ro JY; Shen SS; Truong LD
Arch Pathol Lab Med; 2012 Dec; 136(12):1541-51. PubMed ID: 23194047
[TBL] [Abstract][Full Text] [Related]
18. Bellini duct carcinoma: further evidence for this rare variant of renal cell carcinoma.
Rumpelt HJ; Störkel S; Moll R; Schärfe T; Thoenes W
Histopathology; 1991 Feb; 18(2):115-22. PubMed ID: 1707029
[TBL] [Abstract][Full Text] [Related]
19. High-grade urothelial carcinoma of the renal pelvis: clinicopathologic study of 108 cases with emphasis on unusual morphologic variants.
Perez-Montiel D; Wakely PE; Hes O; Michal M; Suster S
Mod Pathol; 2006 Apr; 19(4):494-503. PubMed ID: 16474378
[TBL] [Abstract][Full Text] [Related]
20. Association of urothelial carcinoma of the renal pelvis with papillary and medullary thyroid carcinomas. A new sporadic neoplastic syndrome?
Albores-Saavedra J; Dorantes-Heredia R; Chablé-Montero F; Córdova-Ramón JC; Henson DE
Ann Diagn Pathol; 2014 Oct; 18(5):286-90. PubMed ID: 25175810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
